Twist Bioscience Corp (NASDAQ: TWST) kicked off on Tuesday, up 7.37% from the previous trading day, before settling in for the closing price of $34.34. Over the past 52 weeks, TWST has traded in a range of $23.30-$55.33.
Annual sales at Healthcare sector company grew by 18.31% over the past five years. While this was happening, its average annual earnings per share was recorded -15.55%. With a float of $58.32 million, this company’s outstanding shares have now reached $60.63 million.
Twist Bioscience Corp (TWST) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Twist Bioscience Corp is 4.62%, while institutional ownership is 116.82%. The most recent insider transaction that took place on Dec 22 ’25, was worth 9,434. In this transaction SVP of Human Resources of this company sold 273 shares at a rate of $34.56, taking the stock ownership to the 166,639 shares. Before that another transaction happened on Dec 22 ’25, when Company’s insider sold 324 for $34.56, making the entire transaction worth $11,196. This insider now owns 144,680 shares in total.
Twist Bioscience Corp (TWST) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.53 earnings per share (EPS), higher than consensus estimate (set at -0.63) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.47 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -15.55% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.20% during the next five years compared to 18.31% growth over the previous five years of trading.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
Take a look at Twist Bioscience Corp’s (TWST) current performance indicators. Last quarter, stock had a quick ratio of 3.33. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.31, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach -1.06 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
Twist Bioscience Corp (NASDAQ: TWST) saw its 5-day average volume 1.22 million, a negative change from its year-to-date volume of 1.43 million. As of the previous 9 days, the stock’s Stochastic %D was 66.16%.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 95.77%, which indicates a significant increase from 91.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.73 in the past 14 days, which was lower than the 1.78 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $31.40, while its 200-day Moving Average is $32.38. Nevertheless, the first resistance level for the watch stands at $38.06 in the near term. At $39.25, the stock is likely to face the second major resistance level. The third major resistance level sits at $41.03. If the price goes on to break the first support level at $35.09, it is likely to go to the next support level at $33.31. The third support level lies at $32.12 if the price breaches the second support level.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
The company with the Market Capitalisation of 2.25 billion has total of 61,148K Shares Outstanding. Its annual sales at the moment are 376,570 K in contrast with the sum of -77,670 K annual income. Company’s last quarter sales were recorded 99,010 K and last quarter income was -27,140 K.
